Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Certa Therapeutics
Cura Therapeutics is a biotechnology company that develops drugs to treat fibrotic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Enleofen Bio Pte Ltd
Enleofen is a biotech company that develops antibody therapeutics for fibro-inflammatory diseases.
Sector
Subsector
Keywords
Location
total rounds
Synspira
Synspira Therapeutics develops treatments for cystic fibrosis and rare diseases.
Sector
Subsector
Location
total rounds
total raised
Athersys
Athersys is a biotechnology company focused on developing regenerative medicine therapies for various medical conditions.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 26.07.2023. Their latest investor Hibiscus Capital Management. Their latest round Series A
Perceptive Advisors
Perceptive Advisors is a privately owned hedge fund sponsor that finances global public equity markets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Perceptive Advisors
Perceptive Advisors is a privately owned hedge fund sponsor that finances global public equity markets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Barer & Son Capital
Barer & Son Capital is a venture capital firm focused on investing in the healthcare and life science sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors8
Number of lead investors
Number of investors
Hibiscus Capital Management
Hibiscus Capital Management is a subsidiary of a biotechnology company focused on commercially viable technologies.
Sector
Subsector
count Of Investments
Perceptive Advisors
Perceptive Advisors is a privately owned hedge fund sponsor that finances global public equity markets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Rapha Capital Management
Rapha Capital Management is a venture capital firm that invests in revolutionary ideas in medicine, healthcare and technology.
Sector
Subsector
Location
count Of Investments
People
Founders2
Jordan J. Green
Jordan Green is also an Associate Professor of Biomedical Engineering, Ophthalmology, Oncology, Neurosurgery, and Materials Science & Engineering at the Johns Hopkins University School of Medicine. He is an executive committee member of the Institute for NanoBioTechnology, co-founder of the Translational Tissue Engineering Center at JHU, and part of the Wilmer Eye Institute and the Sydney Kimmel Comprehensive Cancer. He has strong expertise in nanotechnology, biomaterials, and drug delivery that includes doctoral and postdoctoral training at MIT with Institute Professor Robert Langer and consulting/collaborative work with biotechnology companies. He has published over 70 scientific papers in these areas as well as 12 issued or pending patents. He has received numerous honors including the Maryland Outstanding Young Engineer Award, the Biomedical Engineering Society Rita Schaffer Award, the American Institute of Chemical Engineers Nanoscale Science & Engineering Forum Young Investigator Award, the American Society for Gene & Cell Therapy Outstanding New Investigator Award, the Allan P. Colburn Award for Excellence in Publications by the American Institute of Chemical Engineers, the Presidential Early Career Award for Scientists and Engineers, and was named by Baltimore Business Journal as one of the “40 Under 40” and by Popular Science as one of the “Brilliant Ten.” Dr. Green has given more than 65 invited national/international talks and has served on national grant panels for the National Institutes of Health, the National Science Foundation, and the Department of Defense. His work on angiogenesis and on drug delivery has been supported by grants from the National Institutes of Health, the Maryland Technology Development Corporation, the Coulter Foundation, and the Edward N. and Della L. Thome Memorial Foundation, Award in Age-Related Macular Degeneration Research.
current job
organization founded
Jordan J. Green
Aleksander Popel
Aleksander S. Popel is also a Professor of Biomedical Engineering at the Johns Hopkins University School of Medicine. He holds joint appointments as Professor of Oncology in the School of Medicine, and Professor of Chemical & Biomolecular Engineering in the Johns Hopkins Whiting School of Engineering. He is a member of the Institute for Nanobiotechnology, In Vivo Cellular Molecular Imaging Center, and the Sydney Kimmel Comprehensive Cancer Center. His areas of expertise are angiogenesis and microcirculation, systems biology, computational medicine & biology. He published over 300 scientific papers in these areas. He served as a Visiting Professor at MIT and Harvard University. He is the recipient of the Eugene M. Landis Award from the Microcirculatory Society. He delivered keynote addresses for The Virtual Physiological Human (VPH) European Union Physiome Project and Next-Generation Integrated Simulation of Living Matter Project in Japan; he was C. Forbes Dewey Distinguished Lecturer in Biological Engineering at the Massachusetts Institute of Technology, delivered A.C. Suhren Lecture at Tulane University, Robert M. and Mary Haythornthwaite Distinguished Lecturer at Temple University, and Kawasaki Medical Society Lecturer in Japan. He is a Fellow of the American Institute of Medical and Biological Engineering, American Heart Association, American Physiological Society, and American Society of Mechanical Engineers, and an Inaugural Fellow of the Biomedical Engineering Society. He has been a member of editorial boards of biological and biomedical engineering journals. He served in an advisory role to biotech and pharmaceutical companies. He regularly serves on grant review boards and advisory panels at the National Institutes of Health, National Science Foundation, and other US and international funding agencies. His work on angiogenesis at the Johns Hopkins University has been supported by grants from the National Institutes of Health, the Safeway Breast Cancer Foundation, the Maryland Technology Development Corporation, the Coulter Foundation Translational Partnership, and the Edward N. and Della L. Thome Memorial Foundation, Award in Age-Related Macular Degeneration Research.
current job
organization founded
Aleksander Popel
Employee Profiles4
Amir Shojaei
Chief Scientific Officer, EVP-Clinical Development
Activity
Recent News2
The graph reveals the ratio (%) of positive news articles in a chosen time range